Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ZETA vs GSK✓SelectedUSD · GSKZETA vs GSK performance historyLatest closeAs of-2.18%11/16
Stock and ETF performance explorer

ZETA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+303.3%
GSK return
+58.3%
Excess return
+245.0%
Maximum drawdown
-70.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.2%-0.1%-2.1%-2.2%
7D+10.6%-1.3%+11.9%+10.7%
30D+12.7%+2.7%+10.0%+12.4%
3M+23.4%+2.7%+20.7%+23.1%
6M+108.6%+3.3%+105.2%+107.5%
YTD+76.2%+6.5%+69.7%+73.5%
1Y+94.4%+10.7%+83.8%+90.4%
3Y+325.3%+64.4%+260.9%+291.2%
5Y+292.2%+46.7%+245.5%+260.2%
All+303.3%+58.3%+245.0%+279.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling